Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (31-40 of 519) with videos related to

Pageof 52
Sort By:
Current Opinion in Oncology|April 8, 2004
Testicular cancerGary R MacVicar, Kenneth J Pienta
CA: a Cancer Journal for Clinicians|September 17, 2005
Advances in prostate cancer chemotherapy: a new era beginsKenneth J Pienta, David C Smith
Reviews in Urology|September 21, 2006
Rationale for the Radiation Therapy Oncology Group Study RTOG P-0014Howard M Sandler, Kenneth J Pienta
CA: a Cancer Journal for Clinicians|May 23, 2002
The current state of hormonal therapy for prostate cancerBeth A Hellerstedt, Kenneth J Pienta
Urology|April 9, 2002
Mind-body effect: insulinlike growth factor-1; clinical depression; and breast, prostate, and other cancer risk-an unmeasured and masked mediator of potential significance?Mark A Moyad, Kenneth J Pienta
Current Opinion in Oncology|May 1, 2002
Testicular cancerBeth A Hellerstedt, Kenneth J Pienta
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2012
Disrupting the networks of cancerDaniel F Camacho, Kenneth J Pienta
Cancer Metastasis Reviews|January 7, 2014
A multi-targeted approach to treating bone metastasesDaniel F Camacho, Kenneth J Pienta
Journal of the National Cancer Institute|March 18, 2010
Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growthJian Zhang, Yi Lu, Kenneth J Pienta
Cytokine & Growth Factor Reviews|December 17, 2009
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasisJian Zhang, Lalit Patel, Kenneth J Pienta
Pageof 52

Showing results (31-40 of 519) with videos related to

Sort By:
Pageof 52
Current Opinion in Oncology|April 8, 2004
Testicular cancerGary R MacVicar, Kenneth J Pienta
CA: a Cancer Journal for Clinicians|September 17, 2005
Advances in prostate cancer chemotherapy: a new era beginsKenneth J Pienta, David C Smith
Reviews in Urology|September 21, 2006
Rationale for the Radiation Therapy Oncology Group Study RTOG P-0014Howard M Sandler, Kenneth J Pienta
CA: a Cancer Journal for Clinicians|May 23, 2002
The current state of hormonal therapy for prostate cancerBeth A Hellerstedt, Kenneth J Pienta
Urology|April 9, 2002
Mind-body effect: insulinlike growth factor-1; clinical depression; and breast, prostate, and other cancer risk-an unmeasured and masked mediator of potential significance?Mark A Moyad, Kenneth J Pienta
Current Opinion in Oncology|May 1, 2002
Testicular cancerBeth A Hellerstedt, Kenneth J Pienta
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2012
Disrupting the networks of cancerDaniel F Camacho, Kenneth J Pienta
Cancer Metastasis Reviews|January 7, 2014
A multi-targeted approach to treating bone metastasesDaniel F Camacho, Kenneth J Pienta
Journal of the National Cancer Institute|March 18, 2010
Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growthJian Zhang, Yi Lu, Kenneth J Pienta
Cytokine & Growth Factor Reviews|December 17, 2009
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasisJian Zhang, Lalit Patel, Kenneth J Pienta
Pageof 52